Hamilton, ON - Patients on long-term steady-dose warfarin therapy who have stable international normalized ratios (INRs) for at least six months can safely go 12 weeks between dose assessments, a new ...
Please provide your email address to receive an email when new articles are posted on . Venous thromboembolism causes substantial morbidity and mortality in patients with cancer. Patients with cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback